Skip to main content
WAVERLEY PHARMA INC. logo

WAVERLEY PHARMA INC. — Investor Relations & Filings

Ticker · WAVE ISIN · CA94357L1058 LEI · 254900VT8CXPPV1G5Q51 TSXV Manufacturing
Open in API
Filings indexed 110 across all filing types
Latest filing 2021-04-26 Regulatory Filings
Country CA Canada
Listing TSXV WAVE

About WAVERLEY PHARMA INC.

https://www.waverleypharma.com/

Waverley Pharma Inc. is a specialty biopharmaceutical company engaged in the research, development, and commercialization of safe, effective, and affordable therapeutics. The company primarily focuses on oncology, developing treatments such as poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer. Waverley Pharma commercializes its pharmaceutical products in markets including the United Kingdom, evidenced by successful tenders for drugs like Capecitabine with NHS Scotland. Furthermore, the company operates a retail pharmacy in the United States, integrating pharmaceutical innovation with direct patient service operations.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 100% confidence The document is a Management Certification related to Form 13-502F1, which is a regulatory form submitted to the Ontario Securities Commission concerning participation fees for reporting issuers. It includes certification by an officer (Chief Financial Officer) about the accuracy and completeness of the information provided. The content is primarily a certification and fee calculation related to regulatory compliance, not a financial report or detailed financial statements. It does not contain financial results, earnings, or management discussion but is a regulatory filing with officer attestation. Therefore, according to the Certification Rule and the nature of the document, it should be classified as a Regulatory Filing (RNS).
2021-04-26 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to reporting issuers and participation fees, submitted to the Alberta Securities Commission. It includes a management certification by an officer (Chief Financial Officer) certifying the accuracy of the information. The content focuses on market values, trading periods, and fee calculations rather than financial statements or detailed financial performance. The document is primarily a certification form related to regulatory compliance and fee payment, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory submission with officer certification and does not contain substantive financial data or analysis typical of financial reports.
2021-04-26 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings for a venture issuer, signed by the CEO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the financial year ended December 31, 2020. The document is a certification letter and does not contain actual financial data or the full annual report itself. It is primarily an officer certification related to annual filings, which according to the rules should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) or other report types.
2021-04-26 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of annual filings including AIF, annual financial statements, and MD&A for the financial year ended December 31, 2020. The document is primarily an officer certification letter and does not contain actual financial data or the full annual report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) or Management Reports (MDA). The document length is short (3102 characters), consistent with a certification letter rather than a full report.
2021-04-26 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 95% confidence The document is a notice from Computershare to Canadian Securities Regulatory Authorities regarding an upcoming Annual and Special Meeting of Security Holders for Waverley Pharma Inc. It provides details such as meeting type, record dates, meeting date, location, and proxy material handling. The document is short (1025 characters) and serves as an announcement about the meeting rather than the meeting materials or results themselves. It does not contain financial data, voting results, or detailed meeting content. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement related to the meeting but not the meeting materials or voting results themselves.
2021-04-15 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Waverley Pharma's subsidiary has been awarded an exclusive distribution tender for a pharmaceutical product with NHS Scotland. It discusses the business opportunity, expected revenue impact, and company background. There are no financial statements, regulatory filings, or detailed financial data presented. The content focuses on a business update related to a contract award, which is a capital or financing-related announcement. It is not an earnings release, annual report, or any other detailed financial or governance report. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 5555 characters, sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2021-01-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.